Immutep Selects Charles River Laboratories for IMP761's GLP Toxicology Study

Media Release Appointment of Charles River Laboratories to run Immutep’s preclinical toxicology study evaluating the safety and toxicity of IMP761Forms a key step prior to... | May 29, 2023

Related Keywords

Australia ,Sydney ,New South Wales ,Australian ,Chris Basta ,Immutep Limited ,Globenewswire Inc ,Corporate Communications ,Nasdaq ,Charles River Laboratories ,Charles River ,Chief Scientific Officer ,Lymphocyte Activation ,Investor Relations ,Immutep Limited Stock Exchange ,News ,Information ,Press Release ,Media ,Release ,Appointment ,F ,Charles ,Liver ,Laboratories ,O ,Fun ,Reclinical ,Toxicology ,Study ,Valuating ,The ,Safety ,End ,Toxicity ,Mp761forms ,Key ,Step ,Rior Imm Au000000imm6 ,